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Infectious bursal disease virus (IBDV) causes severe immunodeficiency in young chickens by destroying the precursors of
antibody-producing B cells in the bursa of Fabricius. It has been shown that IBDV infection induces apoptosis in chicken
embryo and tissue culture cells. We previously reported that an IBDV mutant lacking the expression of 17-kDa nonstructural
(NS) protein exhibited decreased apoptotic effects in cell culture as compared to the parental IBDV, suggesting that the NS
protein may be involved in induction of apoptosis. Here, we report that the NS protein of IBDV alone is capable of inducing
apoptosis in cell culture. Transfection of chicken B-lymphocyte cell line (RP9) and chicken embryo fibroblast cells with a
plasmid DNA, containing the NS protein gene under the control of the immediate-early promoter-enhancer region of human
cytomegalovirus, induced programmed cell death in both cell lines. Apoptosis changes, such as chromatin condensation,
DNA fragmentation, and the appearance of apoptotic nuclear bodies, were observed in cell cultures 48-h posttransfection.
As reported earlier, the mutant IBDV grew to lower titers with slower replication kinetics and lower cytopathogenicity when
compared to that of the parental virus. Here, we demonstrate that the mutant virus is closely associated with cells and its
yield from the supernatant was approximately 30-fold lower than the wild-type due to increased cell association, indicating
a deficiency in lysis of virus-infected cells. Taken together, our results indicate that the NS protein of IBDV is highly cytotoxic,









Infectious bursal disease, caused by infectious bursal
disease virus (IBDV), is a highly contagious viral disease
of young chickens. The disease is characterized by de-
struction of the lymphoid cells in the bursa of Fabricius
(BF), which leads to severe B-cell suppression (Becht,
1980; Kibenge et al., 1988). Immunosuppression caused
by IBDV in susceptible flocks exacerbates the chicken’s
susceptibility to other etiological agents and reduces the
chicken’s abilities to respond to vaccination (Becht, 1980;
McFerran et al., 1980; Snyder et al., 1988). There are two
distinct serotypes of IBDV, designated as serotypes I and
II. Viruses of serotype I group are pathogenic to chick-
ens, whereas serotype II viruses, mostly isolated from
turkeys, does not replicate in the chicken bursal cells
and are avirulent for chickens (McFerran et al., 1980).
IBDV isolates of serotype I group differ markedly in vir-
ulence because of different replication efficiency in lym-
phoid bursal cells of these isolates (Tsukamoto et al.,
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501995). Recently very virulent and antigenic variants of
IBDV, resistant to current commercial vaccines, have
been isolated from vaccinated flocks (Brown et al., 1994;
nyder et al., 1988). These variant strains are antigeni-
ally different from the classic strains isolated before
985, and very virulent strains cause higher mortality
han classic strains (Nunoya et al., 1992; Snyder et al.,
992).
IBDV belongs to the Avibirnavirus genus of the family
irnaviridae and its genome consists of two segments of
ouble-stranded RNA (Azad et al., 1985; Dobos et al.,
1979). The smaller segment B encodes VP1, a 97-kDa
multifunctional protein with polymerase and capping en-
zyme activities (Spies and Mu¨ller, 1990). The larger seg-
ment A encodes a 110-kDa precursor protein in a single
large open reading frame (ORF), which is processed into
mature VP2, VP3, and VP4 proteins (Azad et al., 1985;
Hudson et al., 1986). VP2 and VP3 are the major struc-
tural proteins of the virion, whereas VP4 is a minor
protein involved in the processing of the precursor pro-
tein (Hudson et al., 1986; Jagadish et al., 1988; Sanchez
and Rodriguez, 1999). VP2, as the major host-protective
immunogen, is responsible for the antigenic variation
(Brown et al., 1994; Snyder et al., 1988; Vakharia et al.,
1994), tissue culture adaptation (Lim et al., 1999), as well
as virulence (Brown et al., 1994; Yamaguchi et al., 1996).
VP3, as a group-specific antigen, forms a complex with
51IBDV 17-kDa NONSTRUCTURAL PROTEIN INDUCES APOPTOSISVP1, which may have an essential role for the morpho-
genesis of IBDV particles (Bo¨ttcher et al., 1997; Lom-
bardo et al., 1999). Segment A also encodes a 17-kDa
nonstructural (NS) protein from a small ORF, which pre-
cedes the major ORF (Mundt et al., 1995). The NS protein
is highly basic, cysteine-rich, and conserved among all
serotype I IBDV strains (.95% identity), suggesting that
this protein might have an important function. In fact, it
was shown that the NS protein of IBDV is not required for
viral replication but plays an important role in pathogen-
esis (Yao et al., 1998).
Earlier, Vasconcelos and Lam reported that IBDV
causes apoptosis in chicken peripheral blood lympho-
cytes (1994). They also suggested that induction of apo-
ptosis in infected cells might contribute to the immuno-
suppressive effect of IBDV. In later studies, it was shown
that expression of VP2 could induce apoptosis in a vari-
ety of mammalian cells but not in cell lines of chicken
origin (Fernandez-Arias et al., 1997). Recently, we dem-
onstrated that a mutant IBDV, which lacked the expres-
sion of NS protein, showed reduced cytopathogenicity
and apoptotic effects in CEF cells (Yao et al., 1998).
Therefore, to determine whether VP2 or NS protein of
IBDV can induce apoptosis in chicken cells, we con-
structed plasmids containing VP2 or NS protein genes,
under the control of the immediate-early promoter-en-
hancer region of human cytomegalovirus and used to
transfect chicken B-lymphocytes (RP9) and chicken em-
bryo fibroblast (CEF) cells. Transient expression of VP2
and NS protein in both cell lines was monitored using
anti-IBDV or anti-NS protein antibodies, and its apoptotic
effect was evaluated by terminal deoxynucleotide trans-
ferase-dUTP nick-end-labeling (TUNEL) assay. In this
report, we present evidence that transient expression of
VP2 or NS protein alone in vitro can induce apoptosis in
RP9 and CEF cells.
RESULTS
The effect of NS protein on viral release and
cytopathogenicity
To make a preliminary assessment of NS protein in
IBDV cytotoxicity, CEF cells were infected with recov-
ered rD78 and its NS protein deficient mutant
(rD78NSD) at an MOI of 1. Cell viability was measured
daily for up to 6 days by trypan blue staining. Cells
infected with rD78NSD IBDV showed no detectable
change in viable cell numbers over the first 2 days,
and then viability decreased gradually to 52% at day 6
postinfection. In contrast, rD78 IBDV-infected cells ex-
hibited a decrease in cell viability over the first 2 days
(about 70%), and considerable amount of cell death
was detected at 3 days postinfection (data not shown).
All these data are in agreement with our previous
study reported earlier (Yao et al., 1998). From theseresults, we infer that the expression of NS protein is
toxic to the cells.
To determine whether the lack of NS protein synthe-
sis will affect viral release in IBDV-infected cells, CEF
cells were infected with equal amounts of rD78 or
rD78NSD virus, and infected cells and supernatant
were harvested separately at different time points
postinfection. Virus titers present in infected cells
(cell-associated) or supernatant (extracellular) were
determined by plaque assay on CEF cells, respec-
tively. Mean values of two independent experiments
were plotted. As shown in Fig. 1A, the yield of cell-
associated and extracellular virus was similar be-
tween parental D78- and rD78-infected CEF at tested
time points. However, the mutant virus displayed strik-
ing differences in replication kinetics of cell-associ-
ated or extracellular virus titers. When compared with
parental D78 or rD78 virus, the rD78NSD mutant ex-
hibited one or two log higher titers in cell-associated
FIG. 1. Replication kinetics of cell-associated virus and extracellular
virus. Monolayers of CEF cells were infected with equivalent amounts
of the indicated viruses at an MOI of 5. (A) Cell-associated viruses and
(B) extracellular viruses were harvested at indicated time points postin-
fection, respectively. The titers of progeny were determined by plaque
assay. F, D78 parental virus; E, rD78 virus; , rD78NSD virus. Virus titer
at each time point is the mean values of three independent experi-
ments with standard deviation.virus (Fig. 1A), but had two or three log lower titers in






















52 YAO AND VAKHARIAbility of rD78NSD-infected cells was two times higher
han that of rD78- or D78-infected cells at 48-h postin-
ection. These results demonstrate that in the absence
f NS protein expression, the mutant rD78NSD virus
could not be efficiently released from the infected
cells.
To compare the size and morphology of plaques
formed by these viruses, CEF cells were infected with the
same amount of rD78 or rD78NSD virus. Two days
postinfection, infected cells were replaced with growth
media containing 1% agarose and incubated for an ad-
ditional 2 days. The infected cells were fixed and
plaques were stained with 1% crystal violet. As shown in
Fig. 2, rD78 virus produced more plaques and caused
greater CPE (B) than that observed in rD78NSD-infected
CEF (A). However, the plaques produced by the mutant
were similar in size to those produced by the parental
virus. Furthermore, the transfectant viruses were purified
by CsCl gradient, and their proteins were characterized
by Western blot analysis, using rabbit anti-IBDV antibod-
ies. The pattern of major viral structural proteins pro-
duced by the mutant virus could not be distinguished
from the proteins synthesized by the parental D78 or
recovered rD78 virus, indicating that the lack of NS
protein expression does not interfere with the process-
ing of the precursor protein. Quantitatively, the level of
RNA replication and the ratio of viral structural proteins
(VP2, VP4, and VP3) of the mutant virus were similar to
that of rD78 or D78 viruses (data not shown). These
results suggest that the expression of NS protein in
IBDV-infected cells is associated with the efficiency of
FIG. 2. Plaque morphology of rD78 and rD78NSD viruses in CEF cell
ith rD78 or rD78NSD viruses at an MOI of 0.01. After absorption for 1 h
nd incubated for 2 days. The monolayer was immobilized with 1% agar
5% formalin, 10% ethanol, 5% acetic acid, and 1% crystal violet for 5 min
y rD78NSD virus (A) or rD78 virus (B) in CEF cells at day 4 postinfecthe virus release, as well as the cytopathogenicity of
infected cells.
s
oThe NS protein or VP2 alone can induce apoptosis in
RP9 and CEF cells
IBDV has been shown to induce programmed cell
death in chicken peripheral blood lymphocytes and
BSC40 cells (Fernandez-Arias et al., 1997; Vasconcelos
and Lam, 1994). Earlier, we reported that an IBDV mutant
(rD78NSD) exhibited a more reduced apoptotic effect
than its parental rD78 virus in infected CEF cells (Yao et
al., 1998). Since the only difference in the proteins pro-
duced following rD78 and rD78NSD virus infection is the
synthesis of NS protein by the former, it suggests that the
expression of NS protein may be directly involved in
causing apoptosis. To analyze this possibility, transient
expression of NS protein in RP9 cells and CEF cells was
performed. In addition, a VP2 transient expression was
also included in parallel for comparison. About 5 mg of
lasmid pcDNA-NSP or pcDNA-VP2, under the transcrip-
ional control of immediate-early promoter-enhancer of
uman cytomegalovirus promoter, was used to transfect
P9 or CEF cells. The efficiency of transfection for RP9
ells and CEF cells, as monitored by X-Gal staining of
ell transfected with pcDNA-LacZ, were approximately
0%. At 48-h posttransfection, the cellular DNAs were
xtracted and analyzed by 1.5% agarose gel electro-
horesis. As shown in Fig. 3A, distinct laddering effect,
ndicative of nucleosomal fragmentation, was detected in
NA samples obtained from RP9 and CEF cells trans-
ected with pcDNA-NSP (Fig. 3A, lanes 3 and 5) or with
cDNA-VP2 (Fig. 3A, lanes 2 and 4). In contrast, no
ignificant amount of DNA degradation occurred in the
ual number of CEF cells in a 60-cm petri dish (106/dish) were infected
C, the inoculum was removed; the cells were rinsed with PBS (pH 7.0)
o days later, the cells were fixed and stained with a solution containing
m temperature, followed by rinsing with distilled water. Plaques formeds. An eq
at 37°
ose. Twample from cells transfected with pcDNA-LacZ vector











53IBDV 17-kDa NONSTRUCTURAL PROTEIN INDUCES APOPTOSISprotein in transfected RP9 cells (Fig. 3B, lanes 2 and 5) or
CEF cells (Fig. 3B, lanes 3 and 6) was demonstrated by
immunoblotting, using rabbit anti-IBDV or rabbit anti-NS
protein antibodies, respectively. No virus-specific pro-
teins were detected in cells transfected with pcDNA-
LacZ (Fig. 3B, lanes 1 and 4).
Apoptosis induced by transient expression of NS pro-
tein or VP2 in RP9 or CEF cells was further confirmed at
the cellular level by TUNEL-labeling, using FITC conju-
gate. Figures 4 and 5 show the results of TUNEL-labeling
in RP9 and CEF cells, respectively. A large number of
TUNEL-positive cells (green signal) were detected in
RP9 or CEF cells transfected with pcDNA-NSP or
pcDNA-VP2 (Figs. 4e and 4h for RP9 cells; Figs. 5c and
5e for CEF cells). In contrast, there were no TUNEL-
positive cells observed in RP9 or CEF cells transfected
with pcDNA-LacZ (Figs. 4b and 5a). In addition, the pres-
ence of NS protein or VP2 expression in transfected RP9
and CEF cells was also identified by IFA (red signal),
FIG. 3. Detection of cellular DNA fragmentation induced by transient
expressing NS protein or VP2 in RP9 or CEF cells. (A) DNA fragmen-
tation detected by 1.5% agarose gel electrophoresis. DNA samples
(’2.0 mg each) were extracted from cells transfected with pcDNA-LacZ
(lanes 1 and 6), pcDNA-VP2 (lanes 2 and 4), and pcDNA-NSP (lanes 3
and 5). (B) Detection of the VP2 or NSP expression in transfected cells
by immunoblot analysis. Lanes 1 and 4 are RP9 or CEF cells trans-
fected with pcDNA-LacZ vector, respectively; lanes 2 and 3, RP9 or CEF
cells transfected with pcDNA-VP2; and lanes 5 and 6, RP9 or CEF cells
transfected with pcDNA-NSP. Fractions of cell samples were detected
by immunoblotting with either rabbit anti-IBDV (lanes 1, 2, and 3) or
rabbit anti-NSP (lanes 4, 5, and 6).using goat anti-rabbit conjugated with Cy-3 (Figs. 4f and
4i for RP9 and Figs. 5d and 5f for CEF cells, respectively).
t
rIn the absence of other viral proteins, the expressed VP2
or NS protein remained exclusively in the cytoplasm and
no nuclear localization of either protein occurred in
transfected RP9 and CEF cells.
To quantitate apoptosis, the TUNEL-positive RP9 or
CEF cells were examined 60-h posttransfection, and the
result of a representative experiment is shown in Fig. 6.
For RP9 cells, about 63% of the transfected cells that
were expressing NS protein, and 41% of the transfected
cells that were expressing VP2, were apoptotic. For CEF
cells, about 20% of the transfected cells were apoptotic
following transfection with pcDNA-NSP and 31% of the
transfected cells were apoptotic when transfected with
pcDNA-VP2. No appreciable levels of TUNEL-positive
cells were detected either in RP9 cells (6%) or in CEF
cells (4%) following transfection with pcDNA-LacZ. Quan-
tification of the TUNEL-positive cells showed that the
percentage of apoptotic RP9 cells transfected with
pcDNA-NSP was significantly higher (about 22%, P ,
0.01) than that of RP9 cells transfected with pcDNA-VP2,
indicating that the NS protein is more toxic to chicken
B-lymphocytes than VP2. In contrast, the percentage of
apoptotic cells in CEF transfected with pcDNA-NSP was
slightly lower (’10%) than that of cells transfected with
pcDNA-VP2. In general, the degree of apoptotic re-
sponse detected in RP9 cells at 60 h following transfec-
tion with pcDNA-NSP or pcDNA-VP2 were much stronger
than that seen in CEF cells (63% versus 22% for pcDNA-
NSP; 41% versus 33% for pcDNA-VP2). This suggests that
chicken B-lymphocytes (RP9 cells) are more sensitive
than CEF cells to the toxic effect induced by NS protein
or VP2.
DISCUSSION
In recent years, a number of animal viruses have been
shown to induce apoptosis, which plays an important
role in the life cycle of these viruses (Shen and Shenk,
1995; Teodoro and Branton, 1997). Infection of cultured
cells with a wide variety of viruses, including herpes
virus, parvoviruses, retroviruses, paramyxoviruses, al-
phaviruses and picornaviruses, results in the activation
of the apoptosis pathway (Meyaard et al., 1992; Morey et
l., 1997; Shen and Shenk, 1995; Tolskaya et al., 1995;
bol et al., 1994). These viruses have evolved genes that
ncode proteins that can effectively suppress or delay
poptosis in cells in order to produce sufficient quanti-
ies of viral progeny (Teodoro and Branton, 1997). It
ppears that a large number of viruses induce apoptosis
t late stages of infection. This process may represent an
mportant step in the spread of progeny to neighboring
ells while also evading the host immune system (Te-
doro and Branton, 1997).
Earlier, Fernandez-Arias and co-workers reported that
ransient expression of VP2 did not cause apoptotic


























T or by i
54 YAO AND VAKHARIAcells, a derivative of African green monkey kidney cell
line. They speculated that the inability of VP2 to induce
apoptosis in CEF could be related to the tropism of the
IBDV Soroa strain used in their study (Fernandez-Arias et
l., 1997). However, our studies demonstrate that tran-
ient expression of IBDV VP2 or NS protein alone can
nduce a programmed cell death response in both RP9
nd CEF cells. To our knowledge, this is the first report
hat demonstrates that a 17-kDa, cysteine-rich, NS pro-
ein of IBDV can induce apoptosis. In a previous study,
e showed that IBDV-induced apoptosis was signifi-
antly reduced in the absence of NS protein expression
nd NS-deficient mutant IBDV exhibited reduced cyto-
athogenicity in CEF cells (Yao et al., 1998). Here, we
emonstrate that the NS-deficient mutant IBDV is closely
ssociated with cells and is not efficiently released from
he infected cells. This suggests an important role for NS
FIG. 4. Induction of apoptosis in chicken B-lymphocyte (RP9) cells tra
ere transfected with pcDNA-LacZ (a, b, and c) or with pcDNA-NSP
osttransfection, the cells were fixed and analyzed for the expression of
r anti-IBDV antibodies. Apoptosis induced by VP2 or NS protein was m
he cells were visualized and photographed either by phase contrastrotein in viral pathogenesis, as it will induce apoptosis
n infected cells and, thereby, could allow the spread ofthe viral progeny to the neighboring cells at late stages
of infection.
Besides this NS protein of IBDV, a number of nonstruc-
tural proteins of animal viruses have been shown to play
a role in viral pathogenesis. For example, the V protein of
Sendai virus and nef product of simian immunodefi-
iency virus were found to be dispensable for viral rep-
ication but essential in vivo pathogenicity (Kato et al.,
997; Kestlar et al., 1991). In chicken anemia virus (an-
ther immunosuppressive virus of poultry), a 14-kDa,
ysteine-rich, NS protein (VP3) was shown to induce
poptosis in lymphoblastoid T cells and was implicated
n pathogenesis (Noteborn et al., 1994). This VP3 protein,
termed apoptin, is capable of inducing apoptosis in hu-
man transformed cells by a process which is indepen-
dent of p53 induction (Oorschot et al., 1997). Unlike VP3,
which regulates the genes involved in apoptosis via the
d with the expression vectors pcDNA-NSP and pcDNA-VP2. RP9 cells
nd f) or with pcDNA-VP2 (g, h, and i) and incubated at 39°C. At 48-h
tein or VP2 (red signal) in RP9 cells by IFA staining with anti-NS protein
d by TUNEL staining, which detects the DNA breakage (green signal).
mmunofluorescence (IF) microscopy.nsfecte
(d, e, a
NS proinduction of endonuclease (Teodoro and Branton, 1997),























55IBDV 17-kDa NONSTRUCTURAL PROTEIN INDUCES APOPTOSISnucleus, suggesting that these two proteins can indi-
rectly activate the pathway for programmed cell death. In
general, apoptosis can be induced by a variety of viral
and nonviral external stimuli, which can converge on a
common intracellular pathway, resulting in the activation
of an endonuclease (Teodoro and Branton, 1997). How-
ever, an extensive search analysis of protein database
with VP2 or NS protein sequences did not show any
homology with currently known apoptotic inducers or
receptors that mediate apoptosis. So it is unlikely that
the NS protein or VP2 mimics the activity of one of these
cellular proteins. The mechanism by which NS protein or
VP2 induce apoptosis has yet to be elucidated. It was
reported that VP2-induced apoptosis could be blocked
by expression of bcl-2, an oncogene product with broad
ntiapoptosis activity (Fernandez-Arias et al., 1997).
hether NS protein causes apoptosis by inhibition of
cl-2 activity needs to be investigated.
In summary, VP2 and the NS protein of IBDV are
FIG. 5. Detection of apoptosis in CEF cells by TUNEL-labeling.
pcDNA-VP2. CEF cells were transfected with pcDNA-LacZ (a and b) or w
At 48-h posttransfection, the cells were fixed and analyzed for the expre
anti-NS protein or anti-IBDV antibodies. Apoptosis induced by VP2 or N
(green signal). The cells were visualized and photographed by immunapable of triggering apoptotic response in both RP9 and
EF cells. The expression of NS protein in IBDV-infected
p
(ells is necessary for efficient release of the virus from
he cells, as well as the cytopathogenicity of infected
ells. Since the NS protein-deficient mutant IBDV exhib-
ted significantly reduced apoptosis than the parental
irus, it implies that NS protein plays an important role in
he regulation of apoptosis in IBDV-infected cells and
BDV pathogenesis. Infection of chickens with IBDV re-
ults in lymphocyte depletion of the bursa follicles with
ubsequent immunosuppression. Since IgM-bearing B-
ymphocytes is the major target cells for this virus, the
roportion of these cells is significantly reduced after
BDV infection. Whether the use of such NS protein-
eficient virus can cause immunosuppression in chick-
ns remains to be seen.
MATERIALS AND METHODS
ells and viruses
Primary chicken embryo fibroblast cells were pre-
lls were transfected with the expression vectors pcDNA-NSP and
NA-NSP (c and d) or with pcDNA-VP2 (e and f) and incubated at 37°C.
f NS protein or VP2 (red signal) in CEF cells by IFA staining with rabbit
in was monitored by TUNEL staining, which detects the DNA breakage
scence (IF) microscopy.CEF ce
ith pcD
ssion oared from 10-day-old eggs as described previously


























56 YAO AND VAKHARIAmaintained in growth medium consisting of M199 and
F10 (50/50% v/v) medium supplemented with 10% fetal
bovine serum (FBS), 100 U/ml of penicillin, and 100 mg/ml
treptomycin at 37°C in a humidified 5% CO2 incubator.
hicken B-lymphocyte suspension cell line (RP9), used
or transient expression assay, was kindly provided by
yun S. Lillehoj (ARS, USDA) and was maintained in
edium containing Leibovitz (L-15) and Coy’s 5A (1:1,
/v), 10% chicken serum, 10% FBS, 5% tryptose phos-
hate broth (TPB), and 200 nM L-glutamine. The RP9 cells
were maintained in an incubator at 39°C with 5% CO2.
arental D78 IBDV or the transcript-derived recombinant
BDV (rD78) and its NS-deficient mutant IBDV, rD78NSD,
ere propagated and titrated in secondary CEF cells, as
escribed (Mundt and Vakharia, 1996; Yao et al., 1998).
irus stocks were established by serial passage of re-
overed viruses in CEF at a multiplicity of infection (MOI)
f 0.1.
ransient expression of NS or VP2 proteins of IBDV
n vitro and detection of apoptosis
To prepare a recombinant expression plasmid, the NS
rotein-coding region in plasmid pUC19D78A was am-
lified by PCR using a pair of oligonucleotide primers.
he sequences of the primers used for NS gene ampli-
ication were as follows. NSPF (forward primer) 59-
AGCTTGCCGCCGCCATGGTTAGTAGAGATCAGACA-39,
which contains the first ATG codon of the NS protein
gene downstream of a Kozak motif for the initiation of
translation in vertebrate and NSPR (reverse primer) 59-
FIG. 6. Histogram of the percentages of TUNEL-positive cells (me
constructs. This representative experiment was determined from enumTCTAGAGGCAAAAGTCACTCAGGCTTCCTTGGAGGA-39,
which comprises the C-terminal stop codon of the viral
c
fgene. For directional cloning, HindIII and XbaI restriction
site sequences were added at the 59-end of the sense
and antisense oligonucleotide primers, respectively. The
PCR product was cloned into a pCR2.1 vector and ana-
lyzed by sequencing. The NS protein-coding region was
further cloned into the HindIII and XbaI cloning sites of
the eukaryotic expression vector pcDNA3 (Invitrogen),
downstream of the human cytomegalovirus (HCMV) pro-
moter, to produce pcDNA-NSP. Similarly, the coding re-
gion of VP2 was amplified by PCR using plasmid
pUC19D78A as a template. The gene-specific primers
used for the construction of pcDNA-VP2 were as follows:
VP2F (forward primer) 59-AAGCTTGCCGCCGCCATGA-
CAAACCTGCAAGATCAAACCCA-39, and VP2R (reverse
primer) 59-TCTAGAGGCAAAAGTCACTCAAGGTCCTCAT-
CAATC-39. A 1.45-kb HindIII/XbaI fragment, comprising
the entire VP2 coding region of IBDV, was directionally
cloned between HindIII and XbaI sites of pcDNA3 vector
to obtain pcDNA-VP2. Both strands of pcDNA-NSP or
pcDNA-VP2 were analyzed by sequencing to confirm that
no errors were introduced as a result of PCR amplifica-
tion.
In vitro expression of the pcDNA-NSP and pcDNA-VP2
construct were tested in transient expression experi-
ments using chicken B-lymphocyte cells (RP9) and CEF
cells. RP9 cells, grown in T-25 flask, were transfected
with pcDNA3-lacZ vector only, or pcDNA-NSP, or pcDNA-
VP2 (5 mg of plasmid per flask), using Lipofectimine
GIBCO/BRL), as described (Yao et al., 1998). At 48-h
osttransfection, the cells (105) were plated on sterile
stand error of the mean) at 60-h posttransfection with the indicated
of cells in six different microscopic fields of two coverslips.over slips in duplicate and fixed with freshly made 4%

















57IBDV 17-kDa NONSTRUCTURAL PROTEIN INDUCES APOPTOSISature. For the first coverslip, indirect immunofluores-
cence assay (IFA) was carried out using rabbit anti-NSP
or anti-IBDV antibodies and cyanine-3 (Cy-3) conjugated
anti-rabbit secondary antibody (Sigma) to assay the ex-
pression of NS protein or VP2. IFA using rabbit anti-IBDV
polyclonal or rabbit anti-NS monospecific antiserum was
performed exactly as described in previous studies
(Mundt and Vakharia, 1996; Yao et al., 1998). The pres-
ence of expressed NS protein and VP2 in transfected
RP9 or CEF cells was also monitored by immunoblotting.
Immunoblotting was done with rabbit anti-NS protein and
anti-IBDV antibodies, using nitroblue tetrazolium (NBT)
and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) for the
colorimetric reaction. The second coverslip was used for
monitoring of apoptosis. The fixed cells were permeabil-
ized with the treatment of 0.1% Triton X-100 in 1% sodium
citrate solution and analyzed by terminal deoxynucle-
otide transferase-dUTP nick-end-labeling assay, as de-
scribed previously (Mundt and Vakharia, 1996; Yao et al.,
1998).
Characterization of the role of NS protein in IBDV
replication and cytopathogenicity
The growth characteristics of cell-associated or re-
leased viruses from parental D78-, rD78-, or rD78NSD-
infected CEF cells were compared with each other at
various time points postinfection. CEF cells, grown in
T-25 flasks, were infected with parental D78, or with rD78
or rD78NSD IBDV, at an MOI of 0.1. The infected cells and
supernatant were harvested separately. Briefly, at each
indicated time point postinfection, the infected culture
medium and floating cells were removed and clarified by
centrifugation (1000g for 10 min), and the supernatant
as used for titration of the released viruses. The de-
ached cell pellet was collected and placed back in the
riginal flask. At each time point, all the infected cells
adherent and floating cells) were collected, and fresh
199 medium was added. The mixture was then freeze-
hawed three times, followed by centrifugation at 1000g
or 10 min, and supernatants were stored at 220°C until
ll the time points had been collected. The supernatant
as used for titration of infected cell-associated virus.
or each time point, the virus titer was determined by
laque assay on CEF cells in 60-mm plates, as described
arlier (Mundt and Vakharia, 1996; Yao et al., 1998).
The penetration kinetics of rD78 or rD78NSD virus in
CEF cells was also compared at indicated time points
postinfection. CEF cells, grown in a six-well plate, were
infected with 200 PFU (in 0.5 ml vol) of the recovered
viruses for 1 h at room temperature. One hour later, the
inoculum was removed (stored at 4°C for titration), and
pre-warmed medium (37°C) was added into each well.
Immediately thereafter, 10-, 20-, 40-, and 60-min postin-
fection, the wells were rinsed twice with PBS and treated
with sodium citrate buffer (pH 3.0) for 5 min at 37°C toinactivate extracellular viruses. Cells were washed with
PBS and overlaid with 1% SeaPlaque agarose. After 3
days of incubation at 37°C, cells were fixed and stained
with a solution containing 25% formalin, 10% ethanol, 5%
acetic acid, and 1% crystal violet for 5 min at room
temperature. After rinsing the cells with distilled water,
the plaques were counted. The percentage of PFU sur-
viving low pH treatment were calculated and compared
with PBS-treated control.
The cytopathogenicity of rD78 or rD78NSD virus in
CEF cells were also compared by trypan blue exclusion
at indicated time points postinfection. CEF cells were
grown to 80% confluence in a T-25 flask and infected with
parental D78 or with transcript-derived virus stocks at an
MOI of 1. After 1-h absorption at 37°C, viruses were
removed and washed twice with PBS (pH 7.0). Growth
medium (M199 with 5% FBS) was added and the cultures
were incubated at 37°C. At indicated time intervals, the
adherent and floating cells were collected by centrifuga-
tion at 1000g for 5 min after trypsinization. The cell
pellets were resuspended in 10 ml of M199 medium
lacking serum. An aliquot (100 ml) from this cell suspen-
ion was incubated with an equal volume of 0.4% trypan
lue staining solution (GIBCO/BRL) for 5 min at room
emperature. Dead cells that turned blue were counted
nd the percentage of viable cells was calculated.
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